Trade OPTIMIZERx - OPRX CFD

Trading Conditions

• Spread: 0.08
• Long position overnight feeLong position overnight feeMargin. Your investmentUS$1,000.00Overnight feeCharges from full value of position-0.026179 %(-US$1.05)Trade size with leverage ~ US$5,000.00Short position overnight fee ~ US$4,000.00Go to platform: -0.026179%
• Short position overnight feeShort position overnight feeMargin. Your investmentUS$1,000.00Overnight feeCharges from full value of position0.003957 %(US$0.16)Trade size with leverage ~ US$5,000.00Short position overnight fee ~ US$4,000.00Go to platform: 0.003957%
• Overnight fee time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 20
• Stock exchange: United States of America
• Commission on trade: 0%

• Margin. Your investment: US$1,000.00
• Overnight feeCharges from full value of position: -0.026179 %
  (-US$1.05)

• Margin. Your investment: US$1,000.00
• Overnight feeCharges from full value of position: 0.003957 %
  (US$0.16)

Key Stats

• Prev. Close: 9.12
• Open: 8.97
• 1-Year Change: -42.39%
• Day's Range: 8.4 - 8.97

OPTIMIZERx Company profile

About OptimizeRx Corporation

OptimizeRx Corporation is a digital health technology company. The Company enables engagement between life sciences organizations, healthcare providers and patients. It connects approximately 60% of United States healthcare providers and their patients through a technology platform embedded within its own point-of-care network. The Company principal solutions and applications include financial messaging, brand therapeutic support messaging, and brand support. Its financial messaging enables doctors and staffs to access a universe of sample voucher, co-pay coupons and other patient support option through their electronic medical records (EMR) and/or e-prescribe system. Its brand messaging service includes brands awareness message, reminder advertisement, therapeutic support and unbranded messages. Its brand support is focused on educating and working with pharmaceuticals manufacturer on identifying, formulation and implementing new eRx media strategy for promoting their solutions.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, OptimizeRx Corporation revenues increased 42% to $61.3M. Net income totaled $378K vs. loss of $2.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net Income reflects FV Adjustments of Financial Investments decrease from $140K (expense) to $0K.

Equity composition

.